Viewing Study NCT01126502


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-01-16 @ 4:30 AM
Study NCT ID: NCT01126502
Status: TERMINATED
Last Update Posted: 2015-11-04
First Post: 2010-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module